DEA Moves to Classify 7-Hydroxymitragynine as a Schedule I Substance —What the New Federal Crackdown on Concentrated 7-OH Means for Kratom
On July 1, 2026, the U.S. Drug Enforcement Administration moved to place concentrated 7-hydroxymitragynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act — the same category reserved for heroin and LSD. It’s a significant escalation in how the federal government treats one of the most potent compounds associated with the […]
Staying Ahead of the Shift: What the New Federal Focus on Psychiatric Prescribing Means for Risk Mitigation
Updates in clinical guidance and regulations continue to shape how controlled substances are prescribed in 2026. Recent federal activity and clinical guidance brings attention to risk across controlled substance prescribing. Federal focus on prescribing practices In May 2026, the U.S. Department of Health and Human Services announced the MAHA Action Plan1, which includes a focus on reducing […]
Medication Take Back Day: A Practical Tool Providers Can Use to Reduce Medication Risk
Unused and expired prescription medications remain a common and preventable source of medication misuse and accidental harm. For healthcare providers, medication safety extends beyond prescribing and into how medications are stored, monitored, and properly disposed. National Prescription Drug Take Back Day takes place on Saturday, April 25th and it’s a safe, convenient way for patients […]
New ASAM Guidelines for Benzodiazepine Tapering: What Prescribers Need to Know
The American Society of Addiction Medicine (ASAM) has released new clinical practice guidelines for benzodiazepine tapering, providing evidence-based recommendations for all healthcare professionals managing patients on long-term benzodiazepine therapy. These guidelines are particularly important for clinicians managing patients who are prescribed opioids alongside benzodiazepines, given the significant risks associated with this combination. Why These […]
Recovery is REAL: Restoring Every Aspect of Life
At axialHealthcare, we believe in the power of recovery—and in the providers who make it possible. This September, we proudly join SAMHSA in recognizing National Recovery Month with the theme: Recovery is REAL—Restoring Every Aspect of Life. This year’s theme reflects a comprehensive view of recovery, one that goes beyond clinical treatment to encompass the […]
Polydrug Prescribing Under the Microscope: What Providers Need to Know About the 2025 Star Measure on Opioid and Benzodiazepine Prescribing
Some of the most commonly treated symptoms—pain, anxiety, and sleep issues—can carry hidden risks. These conditions are often managed with medications like opioids and benzodiazepines, which may be appropriate individually but dangerous when prescribed together over time. That danger isn’t always visible. Overlapping use can lead to respiratory depression, sedation, falls, cognitive decline, or overdose, […]
FDA Approves Non-Opioid Pain Treatment: What Healthcare Providers Need to Know
The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine), a non-opioid medication for moderate to severe acute pain. 1 This approval expands treatment options for providers who want to reduce opioid exposure while ensuring effective pain relief for patients. For providers, suzetrigine offers a new multimodal pain management tool, particularly for polydrug patients […]
Holiday Overdose Risk: A Call to Action for Healthcare Providers
As we approach the holiday season, a time traditionally filled with joy, celebration, and togetherness, it’s important to recognize that this time of year also brings a significant increase in drug and alcohol-related overdoses. While the holidays can be a time of happiness for many, for others, they are marked by stress, isolation, and emotional […]
October is Substance Use Prevention Month – Tips for Healthcare Providers
October is here, and with it, Substance Use Prevention Month—a reminder of the crucial role healthcare providers play in preventing and addressing substance use disorder (SUD). Prevention is more than a conversation; it’s about taking action through education, early intervention, and ongoing support. As a healthcare provider, your efforts can be pivotal in reducing the […]
Navigating Pain Management: Strategies for a Balanced Approach During Pain Awareness Month and National Opioid Awareness Day
As healthcare providers navigate the complexities of chronic pain management, September offers a unique opportunity for reflection and action. Pain Awareness Month and National Opioid Awareness Day (September 21st) highlight the critical need for evidence-based approaches that prioritize patient outcomes and minimize the risks associated with opioid use. Understanding the Scope of Pain Chronic pain […]